Information  X 
Enter a valid email address

Petro Matad Ltd (MATD)

  Print      Mail a friend

Friday 19 July, 2019

Petro Matad Ltd

Change of Adviser

RNS Number : 0490G
Petro Matad Limited
19 July 2019
 

19 July 2019

Petro Matad Limited ("Petro Matad" or "the Company")

Change of Adviser

Petro Matad (AIM: MATD), the AIM-quoted Mongolian oil explorer, announces the appointment of Shore Capital and Corporate Limited as Nominated Adviser and Shore Capital Stockbrokers Limited as joint Broker, with immediate effect. This follows the acquisition of Stockdale Securities Limited by Shore Capital Market Limited.

 

Further information please contact:

 

Petro Matad Limited

 

Mike Buck, CEO

+976 7014 1099 / +976 7575 1099

 

 

Shore Capital (Nominated Adviser and Broker)

Richard Johnson

Andy Crossley

David Coaten

+44 (0) 20 7408 4090

 

Stifel Nicolaus Europe Limited (Broker)

 

Callum Stewart

Nicholas Rhodes

Ashton Clanfield

+44 (0) 20 7710 7600

 

FTI Consulting (Communications Advisory Firm)

Sara Powell

Ben Brewerton

Genevieve Ryan

+44 (0) 20 3727 1000

 

 About Petro Matad

Petro Matad is the parent company of a group focussed on oil exploration, as well as future development and production in Mongolia. At the current time, Petro Matad holds 100% working interest and the operatorship of three Production Sharing Contracts with the Government of Mongolia. Block XX has an area of 10,367 square kilometres in the far eastern part of the country, and Blocks IV and V have an area of 29,062 square kilometres and 21,143 square kilometres, respectively, in the central western part of the country.

Petro Matad Limited is incorporated in the Isle of Man under company number 1483V. Its registered office is at Victory House, Prospect Hill, Douglas, Isle of Man, IM1 1EQ.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
APPCKFDNCBKDKOD

a d v e r t i s e m e n t